Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, eFFECTOR Therapeutics Inc increased its cash reserves by 70.82%, or 6.17m. Cash Flow from Financing totalled 21.23m or -- of revenues. In addition the company used 29.55m for operations while cash from investing totalled 14.48m.
Cash flow per share | -12.39 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2119 |
---|---|
Tangible book value per share | 0.2119 |
More ▼
Balance sheet in USDView more
Current ratio | 1.03 |
---|---|
Quick ratio | -- |
Total debt/total equity | 22.87 |
---|---|
Total debt/total capital | 0.9581 |
More ▼